Did any serious adverse events occur with AOD-9604
Consumers love the serums ability to improve skin radiance, firmness, elasticity, clarity, and texture
What are Summit Peptides research materials
Activity Modification & Education Cross-training with low-impact activities (cycling, swimming, elliptical) during recovery Gradual return to higher-level sports as pain and function improve Comprehensive patient education on ergonomics, technique, and recurrence prevention 4
peaks during dose escalation, typically mild-moderate Diarrhea -- 10-20%, usually transient Constipation -- 8-15% Vomiting -- 5-15%, more frequent at higher doses Injection site reactions -- 5-10%, mild erythema and pruritus Decreased appetite -- 5-12%, related to mechanism of action Pancreatitis -- rare but monitored (as with all GLP-1/amylin agents) Gallbladder events -- cholelithiasis reported, consistent with rapid weight loss Trial data describes dose titration as central to tolerability -- the 16-week escalation protocol substantially reduced GI adverse events